Akèy › Amiloidoz › Texas › Houston
Etid klinik pou Amiloidoz nan Houston, TX
6 etid pou Amiloidoz ap chèche patisipan nan sit nan ak bò kote Houston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma or Previously Treated Amyloid Light-chain (AL) Amyloidosis
Ap rekriteFaz 1
- MD Anderson Cancer Center, Houston
Non-interventional Study of Patients With Transthyretin (ATTR) Amyloidosis
Ap rekriteEtid obsèvasyon
- Research Site, Houston
TRITON-CM: A Study to Evaluate Nucresiran in Patients With Transthyretin Amyloidosis With Cardiomyopathy
Ap rekriteFaz 3
- Clinical Trial Site, Houston
TRITON-PN: A Study to Evaluate the Efficacy and Safety of Nucresiran in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy
Ap rekriteFaz 3
- Clinical Trial Site, Houston
ConTTRibute: A Global Observational Study of Patients With Transthyretin (TTR)-Mediated Amyloidosis (ATTR Amyloidosis)
Ap rekriteEtid obsèvasyon
- Clinical Trial Site, Houston
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
Ap rekriteFaz 3
- Baylor College of Medicine, Houston
- Houston Methodist Hospital, Houston
Etid Amiloidoz nan lòt vil
- Boston, MA11 etid
- Rochester, MN10 etid
- New York City, NY10 etid
- Dallas, TX9 etid
- Philadelphia, PA7 etid
- Baltimore, MD6 etid
- Durham, NC6 etid
- Portland, OR6 etid
- St. Louis, MO6 etid
- San Diego, CA5 etid
- Cleveland, OH5 etid
- Chicago, IL5 etid
Lòt etid nan Houston
- Kansè Poumon ki pa ti selil145 etid
- Kansè nan tete126 etid
- Kansè (tout kalite)121 etid
- Kansè Metastatik104 etid
- Kansè kolorektal102 etid
- Kansè ovè89 etid
- Leksemi mieloïd egi85 etid
- Kansè poumon78 etid
- Kansè pwostat76 etid
- Kansè Endomèt68 etid
- Kansè pankreyas61 etid
- Melanom59 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.